Volume 97, Issue 5 pp. 786-787
EDITORIAL COMMENT

PCI for left main bifurcation stenting: A treatment paradigm at a crossroads?

Hoshang Farhad MD

Corresponding Author

Hoshang Farhad MD

Division of Cardiology, Lahey Hospital and Medical Center, Burlington, Massachusetts, USA

Correspondence

Hoshang Farhad, Lahey Hospital and Medical Center, Division of Cardiology, Burlington, MA, USA.

Email: [email protected]

Search for more papers by this author
Michael S. Levy MD, MPH

Michael S. Levy MD, MPH

Division of Cardiology, Lahey Hospital and Medical Center, Burlington, Massachusetts, USA

Search for more papers by this author
First published: 14 April 2021

Key Points

  • Percutaneous Coronary Intervention (PCI) with Drug-eluting stents (DES) for significant left main (LM) disease is an accepted therapeutic alternative to coronary artery bypass grafting (CABG) in appropriate patients based on SYNTAX II score stratification.
  • Conflicting outcome data regarding use of single versus dual-stent strategies for LM disease exist.
  • Further prospective randomized data using current generation DES and contemporary PCI techniques will provide more insight into optimal treatment strategies.

CONFLICT OF INTEREST

The authors declare no conflict of interest.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.